Cargando…

Reactivation of p53 via MDM2 inhibition

Detalles Bibliográficos
Autores principales:	Kim, E S, Shohet, J M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	News and Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632320/ https://www.ncbi.nlm.nih.gov/pubmed/26492369 http://dx.doi.org/10.1038/cddis.2015.302

Ejemplares similares

Rewired Notch/p53 by Numb’ing Mdm2
por: Kim, Hyungsoo, et al.
Publicado: (2018)

The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma
por: Lakoma, A, et al.
Publicado: (2015)

MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
por: Woodfield, Sarah E., et al.
Publicado: (2021)

A novel link between the HER2-Akt and MDM2-p53 pathways via CSN6
por: Iyer, Swathi V., et al.
Publicado: (2012)

Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
por: Grinkevich, Vera V., et al.
Publicado: (2022)

PXR interaction with p53: a meeting of two masters
por: Robbins, D, et al.
Publicado: (2016)

Mdm2 pulls the plug on glycolysis
por: Short, Ben
Publicado: (2014)

Depleting stabilized GOF mutant p53 proteins by inhibiting molecular folding chaperones: a new promise in cancer therapy
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction
por: Thayer, Kelly M., et al.
Publicado: (2016)

Novel function of cytoplasmic p53 at the interface between mitochondria and the endoplasmic reticulum
por: Kroemer, G, et al.
Publicado: (2015)

Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma
por: Woodfield, Sarah E., et al.
Publicado: (2021)

MDM4 expression as an indicator of TP53 reactivation by combined targeting of MDM2 and MDM4 in cancer cells without TP53 mutation
por: Hirose, Mitsuaki, et al.
Publicado: (2014)

Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor
por: Costa, Barbara, et al.
Publicado: (2013)

NF-Y joins E2Fs, p53 and other stress transcription factors at the apoptosis table
por: Gatta, R, et al.
Publicado: (2011)

p53-guided response to nucleostemin loss in normal versus cancer cells
por: Tsai, R Y L
Publicado: (2015)

Detection of P53 and Mdm2 in vitiligo
por: Wiwanitkit, Viroj
Publicado: (2013)

The MDM2-p53 pathway revisited
por: Nag, Subhasree, et al.
Publicado: (2013)

Evolution of the p53-MDM2 pathway
por: Åberg, Emma, et al.
Publicado: (2017)

Regulation of p53: a collaboration between Mdm2 and MdmX
por: Pei, Dongsheng, et al.
Publicado: (2012)

Regulation of kidney development by the Mdm2/Mdm4–p53 axis
por: El-Dahr, Samir, et al.
Publicado: (2017)

HDACi inhibits liposarcoma via targeting of the MDM2-p53 signaling axis and PTEN, irrespective of p53 mutational status
por: Ou, Wen-Bin, et al.
Publicado: (2015)

Impact of Reactive Oxygen and Nitrogen Species Produced by Plasma on Mdm2–p53 Complex
por: Attri, Pankaj, et al.
Publicado: (2021)

The Dual Interactions of p53 with MDM2 and p300: Implications for the Design of MDM2 Inhibitors
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2019)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
por: Mrkvová, Zuzana, et al.
Publicado: (2019)

CDK4 inhibition diminishes p53 activation by MDM2 antagonists
por: Sriraman, Anusha, et al.
Publicado: (2018)

Immunohistochemical detection of P53 and Mdm2 in vitiligo
por: Bakry, Ola A., et al.
Publicado: (2012)

Heterogeneous Hydration of p53/MDM2 Complex
por: Guo, Zuojun, et al.
Publicado: (2014)

mRNA Display Selection of an Optimized MDM2-Binding Peptide That Potently Inhibits MDM2-p53 Interaction
por: Shiheido, Hirokazu, et al.
Publicado: (2011)

Inhibition of MDM2 via Nutlin-3A: A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53
por: Walter, Robert F. H., et al.
Publicado: (2018)

Tanning with p53
por: Williams, Ruth
Publicado: (2007)

The RP-Mdm2-p53 Pathway and Tumorigenesis
por: Miliani de Marval, Paula L., et al.
Publicado: (2011)

Controlling the Mdm2-Mdmx-p53 Circuit
por: Waning, David L., et al.
Publicado: (2010)

Fortifying p53 – beyond Mdm2 inhibitors
por: Sriraman, Anusha, et al.
Publicado: (2016)

Mdm1 helps the ER and vacuole stay in touch
por: Short, Ben
Publicado: (2015)

The Role of p53 and MDM2 in Head and Neck Cancer
por: Denaro, N., et al.
Publicado: (2011)

Structural Basis of Competitive Recognition of p53 and MDM2 by HAUSP/USP7: Implications for the Regulation of the p53–MDM2 Pathway
por: Hu, Min, et al.
Publicado: (2006)

The p53–Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans
por: Coffill, Cynthia R., et al.
Publicado: (2016)

Updates from the TP53 universe
por: Pentimalli, Francesca
Publicado: (2018)

Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death
por: Sugimoto, H, et al.
Publicado: (2015)

Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
por: Traweek, Raymond S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hgk8m4m2vn32pc8q1r6obfir3g